Infectious Disease (Urologic)
10 cases on recurrent UTI prophylaxis after exhausting first-line options, resistant-organism antibiotic selection, antibiotic duration around an infected obstructed kidney, asymptomatic bacteriuria before minor procedures, catheter-associated bacteriuria versus true infection, penile prosthesis salvage timing, asymptomatic candiduria management, oral versus intravenous therapy in infant febrile UTI, dual-risk epididymitis treatment, and off-label oral fosfomycin for multidrug-resistant UTI — choose a case below to open its full multi-voice debate.
A single patient, six recurrences into a year of urinary tract infections. The disagreement isn't about which antibiotic works best in general — it's about what's left to prescribe once the three usual first-line options have each been disqualified for a reason specific to her.
A single patient, hours into a second septic-appearing febrile UTI. The disagreement isn't about whether he needs broad coverage tonight — it's about how much weight an eight-month-old resistant culture should carry against a fresh blood culture that hasn't resulted yet.
A single patient, three days into recovery from an infected, obstructed kidney. The disagreement isn't about whether he's improving — it's about what happens to his antibiotics for the three weeks between now and the stone removal his surgical schedule, not his infection, is actually dictating.
A single patient, found bacteriuric on a routine pre-procedure urinalysis. The disagreement isn't about the guideline's existence — it's about whether a simple stent removal actually meets the mucosal-trauma bar the guideline's own exception was written around.
A single patient, thirty-one years into a chronic indwelling catheter. The disagreement isn't about whether his urine changed today — it's about whether an appearance change is the same thing as the localizing finding that would actually justify treating it.
A single patient, three weeks post-implant with early signs of prosthesis infection. The disagreement isn't about whether the device needs to come out — it's about whether tonight's exam still matches the population where immediate salvage and reimplantation actually succeeds.
A single patient, found to have candiduria on a routine post-operative culture. The disagreement isn't about whether her diabetes raised her risk — it's about whether an incidental, asymptomatic finding meets any of the three narrow reasons the guideline actually recommends treating it.
A single patient, eleven weeks old with a first febrile urinary tract infection. The disagreement isn't about whether young infants sometimes need admission — it's about whether she is actually inside the age range the oral-therapy evidence describes, or only close enough to it to sound like she is.
A single patient, presenting with acute epididymitis and two independently plausible explanations. The disagreement isn't about which exposure is real — both are — it's about whether the guideline's risk-based framework was ever meant to force a choice between two genuine risk factors present at once.
A single patient, on her fourth resistant urinary tract infection in six months with one oral option left. The disagreement isn't about which drug her organism is susceptible to — it's about whether a lower-certainty, lower-burden treatment is the right call for a specific 81-year-old, not urinary tract infections in general.